AMT
59
13
NSC
42
3
LH
50
2
GRMN
48
2
WFC
72
3
A
44
3
VRSN
53
4
ESS
59
5
CMS
68
3
ROK
32
4
SWKS
44
2
NRG
60
6
FOXA
56
4
GLW
49
3
ACN
29
-4
STT
56
3
NDAQ
59
4
RRC
69
4
NAVI
30
6
T
71
3
AMT
59
13
NSC
42
3
LH
50
2
GRMN
48
2
WFC
72
3
A
44
3
VRSN
53
4
ESS
59
5
CMS
68
3
ROK
32
4
SWKS
44
2
NRG
60
6
FOXA
56
4
GLW
49
3
ACN
29
-4
STT
56
3
NDAQ
59
4
RRC
69
4
NAVI
30
6
T
71
3
Financhill
Back

Bon Natural Life 10K Form

Buy
64

BON
Bon Natural Life

Last Price:
$1.39
Seasonality Move:
-34.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BON News And Ratings

See the #1 stock for the next 7 days that we like better than BON

BON Financial Statistics

Sales & Book Value

Annual Sales: $23.8M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $25.95
Price / Book: 0.13

Profitability

EPS (TTM): 2.10130
Net Income (TTM): $2.5M
Gross Margin: $7.1M
Return on Equity: 6.8%
Return on Assets: 5.14%

Bon Natural Life Earnings Forecast

Key Bon Natural Life Financial Ratios

  • The Gross Profit Margin over the past 7 years for BON is 29.82%.
  • The Selling, General & Administrative Expenses for BON have been equal to 15.16% of Gross Profit Margin.
  • The Research & Development expenses have been 6.80% of Revenue.
  • The Interest Expense is 76.16% of Operating Income.
  • The Net Earning history of BON is 1.67% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Bon Natural Life Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Chemicals
Sector: Materials
Current Symbol: BON
Website: bnlus.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 2.44
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 8.24
Forward P/E Ratio: 0

BON Technical Analysis vs Fundamental Analysis

Buy
64
Bon Natural Life (BON) is a Buy

Is Bon Natural Life a Buy or a Sell?

  • Bon Natural Life stock is rated a Buy
    The current Bon Natural Life [BON] share price is $1.40. The Score for BON is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.